USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth

Participants:

Hicham Naim VP, Head of Strategy & TransformationTakedaOther
Other
Hicham Naim
VP, Head of Strategy & TransformationTakeda
Laura Cohen Director, Marketing, PAH (Rare Disease)Merck
Laura Cohen
Director, Marketing, PAH (Rare Disease)Merck
Abhimanyu Verma Chief Technology OfficerSOPHiA GENETICS
Abhimanyu Verma
Chief Technology OfficerSOPHiA GENETICS
Armin Furtwaengler Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbHOther
Other
Armin Furtwaengler
Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbH
Arthur Bretonnet Global Digital Innovation LeadUCB Pharma
Arthur Bretonnet
Global Digital Innovation LeadUCB Pharma
Hugh Lloyd-Jukes CEOOxehealth
Hugh Lloyd-Jukes
CEOOxehealth
Jim O'Donoghue PresidenS3 Connected HealthProfessional Services
Professional Services
Jim O'Donoghue
PresidenS3 Connected Health
Jo Masterson CEO2Morrow, Inc.Health Tech & Solutions
Health Tech & Solutions
Jo Masterson
CEO2Morrow, Inc.
Jyri Yli-Villamo Head of Pharma Global Strategic PartnershipsKaiku Health
Jyri Yli-Villamo
Head of Pharma Global Strategic PartnershipsKaiku Health
Louis Payet CEOPeach Health
Louis Payet
CEOPeach Health
Mike Pace Founder & CEOPalmHealthCoProfessional Services
Professional Services
Mike Pace
Founder & CEOPalmHealthCo

About this Meeting

Pharma companies are accelerating their incorporation of digital tools across all aspects of their business with Digital Therapeutics (DTx) being an element of this digital transformation. However, what DTx means in practice for Pharma companies is still primarily pilots as companies grapple to see how to monetize DTx in a traditional pharma business. Join us in this informal conversation with other senior leaders where we will talk about: 

  •  Drivers for both DTx and pharma companies for partnering up 
  •  How to monetize DTx in a traditional pharma business (ROI)? 
  •  Most pharma-DTx collaborations have been companion-style DTx as opposed to standalone therapies; will this change in the next few years?  
  •  From an organizational perspective, what are the key changes pharma needs to do to successfully integrate DTx in their business model? 

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

USA Event Dates

  • 2026 | HLTH: Nov 15 – 18 | Las Vegas, NV | Register | Sponsor
  • 2027 | ViVE: Mar 14 – 17 | Nashville, TN | Be First to Know | Sponsor
  • 2027 | HLTH: Oct 17 – 20 | Las Vegas, NV
  • 2028 | HLTH: Nov 12 – 15 | Las Vegas, NV

Europe Event Dates

  • 2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
  • 2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.

© 2026 HLTH, INC. by Hyve Group - All Rights Reserved

About usPrivacy Policy Contact us